Laboratory Testing for Tie-2 Expressing Monocytes (TEMs) in Blood

计划入组 20 人 · 首次发布于 2012 年 3 月 5 日

The Role of Angiopoietin, Tie-2, and Vascular Endothelial Growth Factor (VEGF) in Sepsis-Induced Multiple Organ Dysfunction Syndrome (MODS)

计划入组 120 人 · 首次发布于 2009 年 5 月 27 日

The TIME-2 Study: A Phase 2 Study of AKB-9778, a Novel Tie-2 Activator, in Patients With Diabetic Macular Edema

计划入组 144 人 · 首次发布于 2014 年 1 月 31 日

Tie-2 kinase inhibitors (GlaxoSmithKline)

Cancer vaccine Tie-2(Scancell)

MEREO BIOPHARMA 2 LIMITED

United Kingdom

UpJohn US 2 LLC

United States

RIVER 2 RENAL CORP.

United States

ARDS Clinical Pipeline Expands with 50+ Companies Developing Novel Therapies

EYP-1901 Shows Promise in Reducing Treatment Burden for Wet AMD Patients in Phase 2 DAVIO-2 Trial

ISPE Celebrates 20th Anniversary with Announcement of 2025 Facility of the Year Awards Winners